Related Experiment Videos
IgE-dependent expression of interleukin-5 mRNA and protein in human lung: modulation by dexamethasone
M C Glaum1, J S Jaffe, D H Gillespie
1Department of Medicine, Hahnemann University, Philadelphia, Pennsylvania 19102, USA.
Abstract:
mRNA and protein expression of the Th2 cytokines IL-4 and IL-5 from human lung were examined during the first 4 hr following IgE-mediated triggering, a time representative of the evolving late-phase reaction (LPR). Lung explants were incubated for 16 hr at 37 degrees C in culture media alone or with added dexamethasone (10(-6) M), washed, and then challenged with buffer or anti-IgE (3 micrograms/ml). Using RNase protection assays, in 16/16 individual lungs IL-5 mRNA expression was observed at 4 hr following anti-IgE and at no points following buffer challenge. Fragments released 1129 +/- 499 ng of IL-5/g wet wt over a 24-hr period (mean +/- SEM, n = 5). Neither IL-4 transcripts nor protein were detected in any anti-IgE challenges. Both the IgE-mediated IL-5 mRNA and protein responses were below the limits of detection following dexamethasone preincubation, suggesting a mechanism for the potent inhibitory effects of these agents observed in the LPR.
Insights
This study shows that immunoglobulin E (IgE)-mediated triggering in human lungs significantly increases interleukin-5 (IL-5) mRNA and protein during the late-phase reaction. Dexamethasone effectively inhibits this IL-5 response.
Area of Science:
- Immunology
- Respiratory Medicine
- Molecular Biology
Background:
- The late-phase reaction (LPR) is a critical phase in allergic responses.
- Understanding the molecular mechanisms of LPR, particularly cytokine involvement, is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression of Th2 cytokines, specifically IL-4 and IL-5, in human lung tissue during the early stages of IgE-mediated LPR.
- To determine the effect of dexamethasone on IL-5 production in response to IgE triggering.
Main Methods:
- Human lung explants were cultured and then challenged with anti-IgE to mimic IgE-mediated triggering.
- Ribonuclease (RNase) protection assays were used to quantify IL-5 mRNA expression.
- IL-5 protein levels were measured in culture supernatants.
- Dexamethasone was used as a pre-treatment to assess its inhibitory effects.
Main Results:
- Interleukin-5 (IL-5) mRNA was consistently detected in human lungs 4 hours after IgE-mediated triggering.
- Significant levels of IL-5 protein were released following anti-IgE challenge.
- Neither IL-4 mRNA nor protein was detected under the experimental conditions.
- Dexamethasone pre-incubation completely inhibited both IgE-mediated IL-5 mRNA and protein responses.
Conclusions:
- IgE-mediated triggering in human lungs induces a robust IL-5 response, characteristic of the early LPR.
- The potent inhibition of IL-5 by dexamethasone suggests a key mechanism for its therapeutic efficacy in allergic inflammatory conditions.
- Further research into IL-5's role in LPR could lead to improved treatment strategies for allergic lung diseases.